Delivery Order SPE2DX22D0010-SPE2D824FLC85
Award Date
3/26/24
Potential Completion Date
3/27/24
Potential Value
$1.4K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a $1,268.31 firm fixed price delivery order for the supply of XTAMPZA ER 36 MG capsules. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.43 firm fixed-price delivery order contract covers the supply of XTAMPZA ER 27 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,518.80, is a delivery order for the supply of XTAMPZA ER CAPS 36MG, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,837.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the supply of XTAMPZA ER 36 MG CAPSULE 100S, a type of medication. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
The federal contract award, with ID SPE2DX22D0010|SPE2D825FCC09, was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,108.47 Firm Fixed Price contract is for the delivery of XTAMPZA ER CAPS 18MG. This contract is not designated as a set-aside. The award is a Delivery Order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the delivery of XTAMPZA ER 36 MG capsules in 100-count bottles. The award, valued at $1,268.31, is a firm fixed price delivery order with an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. Additionally,...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,706.55 firm-fixed-price delivery order is for the supply of 4,565,048,033 units of the prescription drug Xtampza ER 27 mg capsule. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00, that serves as the primary vehicle for the company to...
This federal contract award is for the delivery of 4566421206 XTAMPZA ER 27 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,061.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,208.98 firm fixed price contract is for the delivery of XTAMPZA ER 13.5 MG capsules, a specialty medication product. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award, with the ID SPE2DB20D1109|SPE2DB25FN42S, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,778.15 and a completion date of January 22, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...